The following NIH funding opportunities have been brought to our attention. These may be applicable to research using NHLBI Biorepository and/or Data Repository resources.
These funding opportunities are not administered by the BioLINCC program. Inquiries regarding research topic eligibility and other administrative matters should be directed to the staff offices identified in the announcements. However, BioLINCC staff will be pleased to provide assistance if needed to search for suitable repository resources for the proposed research. To search for studies or submit a request for resources available through BioLINCC, follow the instructions on the Studies page.
Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate exploratory research relevant to heart, lung, and blood diseases and sleep disorders using the existing biospecimen collections that are stored in the NHLBI Biorepository, thereby maximizing the scientific value of the stored collections and providing researchers with an opportunity to generate preliminary data for subsequent research proposals.
For more information on RFA-HL-23-018 please visit:
PAR-23-036 Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses using existing human datasets in areas relevant to the National Heart, Lung, Blood Diseases and Sleep Disorders Institute (NHLBI) scientific mission. The FOA aims to stimulate the use of existing human datasets to investigate novel scientific ideas, and/or generate new models, systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. Generation of new primary data is not allowed.
For more information on PAR-23-036 please visit:
Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health (Parent R01)
The purpose of this Notice of Special Interest (NOSI) is to stimulate research and advancement of methodologies in data science in heart, lung, blood, or sleep (HLBS) biomedical research, and ultimately translate new insights into decision-making to improve health. For this NOSI, NHLBI will only accept applications in response to PA-20-183 and PA-20-185. For PA-20-183, only mechanistic clinical trials will be accepted in accordance with NOT-HL-19-690.
For more information on NOT-HL-22-001 please visit: